Hercules Technology's Kathy Conte to Speak on Life Sciences Financing Panel at Bio International Convention
PALO ALTO, Calif.--(BUSINESS WIRE)--
Hercules Technology Growth Capital, Inc. (NASDAQ: HTGC), the leading specialty finance company providing venture debt and equity to venture capital and private equity backed technology and life science companies at all stages of development, today announced that Kathy Conte, managing director of life sciences, will be one of five industry experts featured on a life sciences financing panel at the 2008 Bio International Convention, June 17-20, 2008, at the San Diego Conference Center. Ms. Conte will present on the panel entitled, "The Evolution of Capital: New Sources of Financing in the Life Sciences," from 1:30-3:00 p.m. PT on Tuesday, June 17.
As part of the breakout session, Ms. Conte will discuss how venture capital has evolved for life science companies. Consistent with Hercules' mission to provide alternative sources of needed growth capital to life sciences companies in order to help them reach important milestones, Ms. Conte will offer her perspective on the problems associated with the traditional venture funding model and discuss additional sources of financing for emerging life science companies.
The Bio International Convention was established to provide biotechnology professionals with current industry insights from world-renowned speakers and panelists. The four-day event will feature 2,200 exhibiting companies, representing more than 65 global countries.
About Hercules Technology Growth Capital, Inc.:
Hercules Technology Growth Capital, Inc. is a NASDAQ traded specialty finance company providing debt and equity growth capital to technology and life science companies at all stages of development. Founded in December 2003, the company primarily finances privately held companies backed by leading venture capital and private equity firms. Hercules invests in a broad range of ventures active in technology and life science industries and offers a full suite of growth capital products at all levels of the capital structure. The company is headquartered in Palo Alto, Calif. and has additional offices in the Boston, Boulder, San Diego, Columbus and Chicago areas. Providing capital to publicly-traded or privately-held companies backed by leading venture capital and private equity firms involves a high degree of credit risk and may result in potential losses of capital. For more information, please visit www.HTGC.com.
Companies interested in learning more about financing opportunities should contact info@HTGC.com, or call 650.289.3060.
Forward-Looking Statements:
The statements contained in this release that are not purely historical are forward-looking statements. These forward-looking statements are not guarantees of future performance and are subject to uncertainties and other factors that could cause actual results to differ materially from those expressed in the forward-looking statements including, without limitation, the risks, uncertainties and other factors we identify from time to time in our filings with the Securities and Exchange Commission. Although we believe that the assumptions on which these forward-looking statements are reasonable, any of those assumptions could prove to be inaccurate and, as a result, the forward-looking statements based on those assumptions also could be incorrect. You should not place undue reliance on these forward-looking statements. The forward-looking statements contained in this release are made as of the date hereof, and Hercules assumes no obligation to update the forward-looking statements for subsequent events.
Source: Hercules Technology Growth Capital, Inc.
Released June 10, 2008